These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4231370)

  • 41. [Management of virilization with an antiandrogen-containing contraceptive].
    Apró G; Sas M
    Orv Hetil; 1981 Jul; 122(30):1821-4. PubMed ID: 6458007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advantages of the new progestins.
    Stevenson AM
    MCN Am J Matern Child Nurs; 1997; 22(6):338. PubMed ID: 9631631
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of cyproterone acetate on skin surface lipids.
    Fanta D; Müller MM
    Acta Derm Venereol; 1978; 58(1):85-7. PubMed ID: 75644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reversed sequential therapy of hirsutism using cyproterone acetate. I. Further clinical observations.
    Leo-Rossberg I; Laur S; Zielske F; Hammerstein J
    Acta Endocrinol Suppl (Copenh); 1971; 152():14. PubMed ID: 4251533
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial.
    Maloney JM; Dietze P; Watson D; Niknian M; Lee-Rugh S; Sampson-Landers C; Korner P
    Obstet Gynecol; 2008 Oct; 112(4):773-81. PubMed ID: 18827119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acne of the fulminans type following testosterone therapy in three excessively tall boys.
    Traupe H; von Mühlendahl KE; Brämswig J; Happle R
    Arch Dermatol; 1988 Mar; 124(3):414-7. PubMed ID: 2964226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Medical indications for the prescription of ovulation inhibitors in gynecologic practice].
    Willmes HG
    Med Welt; 1969 Mar; 10():526-31. PubMed ID: 4239080
    [No Abstract]   [Full Text] [Related]  

  • 48. [Anti-androgenic steroid cyproterone acetate. Clinical pharmacology and therapeutic use in hirsutism and acne].
    van Wayjen RG; van den Ende A
    Ned Tijdschr Geneeskd; 1976 Jan; 120(5):189-95. PubMed ID: 129710
    [No Abstract]   [Full Text] [Related]  

  • 49. Advantages of the new progestins.
    Stevenson AM
    MCN Am J Matern Child Nurs; 1998; 23(1):56. PubMed ID: 9470365
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical treatment results of treating androgenization symptoms in women with preparation Diane-35].
    Marianowski L; Cyganek A; Grzechocińska B
    Wiad Lek; 1994 Oct; 47(19-20):745-6. PubMed ID: 7483620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Systemic treatment of acne: recommendations. The French Agency of Sanitary Safety of Health Products].
    Ann Dermatol Venereol; 1999 Mar; 126(3):233-4. PubMed ID: 10394435
    [No Abstract]   [Full Text] [Related]  

  • 52. [Systemic treatment of acne: proposal. The French Agency of Sanitary Safety of Health Products].
    Ann Dermatol Venereol; 1999 Mar; 126(3):224-31. PubMed ID: 10394434
    [No Abstract]   [Full Text] [Related]  

  • 53. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial.
    Plewig G; Cunliffe WJ; Binder N; Höschen K
    Contraception; 2009 Jul; 80(1):25-33. PubMed ID: 19501212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acne.
    Millikan LE
    Skinmed; 2004; 3(2):93-4. PubMed ID: 15010635
    [No Abstract]   [Full Text] [Related]  

  • 55. [Oral contraceptives and common acne].
    Winkler K
    Hautarzt; 1972 Jun; 23(6):241-3. PubMed ID: 4262358
    [No Abstract]   [Full Text] [Related]  

  • 56. [Experiences in dermatologic practice with combined external treatment of acne with benzoyl peroxide and erythromycin].
    Gerny H
    Z Hautkr; 1984 Jul; 59(13):888-93. PubMed ID: 6235684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical experience with Diane-35, currently the lowest dose antiandrogenic hormonal ovulation inhibitor, in mild to moderative androgenization in the female].
    Kaiser E
    Geburtshilfe Frauenheilkd; 1986 Oct; 46(10):738-42. PubMed ID: 2948866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of ethinyl estradiol and desogestrel on clinical and metabolic parameters in Indian patients with polycystic ovary syndrome.
    Bhattacharya SM; Ghosh M; Basu R
    J Obstet Gynaecol Res; 2012 Jan; 38(1):285-90. PubMed ID: 22070369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Systemic hormonal therapy of female acne. Personal considerations].
    Lo Presti G
    Minerva Dermatol; 1966 Oct; 41(10):373-8. PubMed ID: 4230837
    [No Abstract]   [Full Text] [Related]  

  • 60. TREATMENT of acne vulgaris and of acne rosacea.
    Postgrad Med; 1953 Feb; 13(2):A-18-20. PubMed ID: 13037549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.